Latest Sydney News

Lendlease appoints seasoned real asset executive Nick O’Neil as CEO, marking a leadership shift aligned with its strategic reset and portfolio simplification.

Diamond Infraco has extended its takeover offer for Atlas Arteria to 25 June 2026, waiving several key conditions and adjusting the timeline for regulatory updates.

ImpediMed has successfully closed an oversubscribed Share Purchase Plan, raising $2.1 million following a $13.2 million institutional placement. The strong shareholder response underscores confidence ahead of a key shareholder vote.

OncoSil Medical has cleared a major regulatory hurdle as its Humanitarian Device Exemption application nears FDA approval, while its TRIPP-FFX trial shows promising results combining OncoSil with standard chemotherapy for pancreatic cancer.

Qube Holdings confirms progress on regulatory approvals for its $5.20-per-share takeover scheme by Rubik Australia, with a shareholder meeting scheduled for June 16 and plans for a special dividend.

Horizon Oil confirms its takeover offer for Cue Energy shares as best and final, holding a majority stake and with all regulatory approvals cleared. The offer period closes on 19 June 2026, with liquidity risks flagged for minority shareholders who abstain.

EBR Systems has secured A$106.4 million through a fully underwritten institutional placement and entitlement offer, positioning the company for further commercial expansion of its wireless cardiac pacing technology.

Atlas Arteria has lodged its second supplementary target's statement, maintaining its firm recommendation to reject IFM’s conditional takeover offer despite an extension of the bid period to 18 June 2026.

FOS Capital's Aldridge Traffic Systems subsidiary has landed a $0.5 million contract to supply advanced ITS lighting for the NELP Eastern Freeway Upgrade, marking its largest order since acquisition and boosting the group’s order book to $9 million.

Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.

Diamond Infraco 1 Pty Ltd, the IFM Global Infrastructure Fund subsidiary, has pushed back the closing date for its Atlas Arteria takeover offer to 18 June 2026. None of the offer conditions have been met yet, prolonging uncertainty around the bid’s completion.

OMG Group's net sales hit approximately $6.2 million on a moving annual total basis, marking a 57% increase year-on-year, driven by ecommerce growth and key international distribution deals.